NOV 16, 2020 7:00 AM PST

Measles Is Back and COVID Isn't Helping

WRITTEN BY: Tara Fernandez

Measles is a highly contagious and airborne viral disease. There is no treatment besides supportive care once a person becomes infected with the virus, of which children are the most common victims. Overall, vaccination has slashed measles-related deaths by 80 percent between 2000 and 2017. The measles vaccine, developed in the early 1960s is safe and very effective. So why then has measles come back with a vengeance, causing deaths to skyrocket worldwide?

The problem seems to lie in gaps in herd immunity. To prevent disease outbreaks, experts estimate around 95 percent of people within a community need to be immunized. According to Natasha Crowcroft, from WHO’s Measles and Rubella Control in Geneva, global vaccinations have tapered off at around 84 to 85 percent, which over time leads to the accumulation of susceptible children and the onset of outbreaks.

A new study that tracked outbreaks across nine countries highlights the importance of vaccination coverage in limiting measles-related deaths. Different obstacles stand in the way of this coverage amongst different communities. In Samoa, for instance, fewer children were taken for their measles shots as fearful parents reacted to a medical error in 2018 that led to the death of two infants. In Ukraine, health care workers were not confident about the efficacy of vaccines and consequently didn’t push for them to be administered.

COVID-19 has further complicated matters: disruptions in immunization programs during lockdowns and the economic slump increasing rates of malnutrition being among factors contributing to this. Vitamin deficiencies in children can lead to more severe and life-threatening forms of the disease. “These issues tend to cluster in the same communities, exacerbating the total effect and increasing inequity,” said Crowcroft.

Winning the war against measles would mean regaining control of global immunization programs, say experts. Emerging technologies such as vaccine patches that don’t require cold storage and injections could also be transformative in the future. For now, it seems measles continues to have the upper hand with case numbers on the steady incline.

 


Sources: Science News, CDC.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 12, 2020
Immunology
Is Gluten Becoming More Immunoreactive?
AUG 12, 2020
Is Gluten Becoming More Immunoreactive?
In recent years, the number of people diagnosed with celiac disease has increased drastically, even with many undiagnose ...
AUG 21, 2020
Microbiology
Vaccine Aimed at Fungi May Also Protect Against MRSA
AUG 21, 2020
Vaccine Aimed at Fungi May Also Protect Against MRSA
Staphylococcus aureus is a common bacterium. If it stays on the skin it's harmless, but if it gets into the bloodstream, ...
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
NOV 04, 2020
Coronavirus
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
NOV 04, 2020
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
COVID-19, the illness caused by the pandemic virus SARS-CoV-2, is known to cause blood clots all over the body in some p ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
Loading Comments...